Xtant Medical

Xtant Medical Announces First Quarter 2018 Financial Results

BELGRADE, MT / ACCESSWIRE / May 8, 2018 / Xtant Medical Holdings, Inc. (NYSE American: XTNT), a leader in the development of regenerative medicine products and medical devices, today reported financial and operating results for the first quarter of 2018.First Quarter 2018 Financial Highlights and Recent Accomplishments: Revenue for the first quarter 2018 was $17.9 million, down from $22.1 million for the first quarter of 2017 Gross Margin for the first quarter 2018 was 68.2%, compared to 67.5% for the first quarter of 2017 The Company reported a net loss from operations of $5.3 million, compared to $5.8 million during the first quarter of 2017 The Company reported non-GAAP Ad…